Brief: Kura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data
02/06/2025 23:03
June 2 (Reuters) - Kyowa Kirin Co Ltd 4151.T: KURA ONCOLOGY INC: FDA PDUFA TARGET ACTION DATE OF NOVEMBER 30 FOR ZIFTOMENIB Source text: ID:nGNXc1FygT Further company coverage: 4151.T ((Reuters.Briefs@thomsonreuters.com;))